Hsinchu, Taiwan

Kun-Ju Lin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Tsing Hua University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kun-Ju Lin. Retrieved from https://idiyas.com/inventor/kun-ju-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Kun-Ju Lin

Introduction

Kun-Ju Lin is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of radiochemistry, particularly in the development of methods for preparing radiolabeled compounds. His work has implications for medical imaging and cancer research.

Latest Patents

Kun-Ju Lin holds a patent for a method of preparing [I]Iodooctyl fenbufen amide. This invention boasts a radiochemical yield of 15%, a specific activity of 37 GBq/μmol, and a radiochemical purity of 95%. The method is designed for use as a tracer in single photon emission computed tomography (SPECT) to estimate the distribution of cyclooxygenase. By leveraging the binding characteristics of iodine isotope-labeled compounds, this invention can help estimate tumor development and metastasis, correlating inflammation with tumor lesions.

Career Highlights

Kun-Ju Lin is affiliated with Tsinghua University, where he continues to advance research in his field. His innovative approaches have garnered attention and recognition within the scientific community.

Collaborations

He has collaborated with notable colleagues, including Chung-Shan Yu and Ho-Lien Huang, contributing to various research projects and enhancing the impact of his work.

Conclusion

Kun-Ju Lin's contributions to radiochemistry and medical imaging exemplify the importance of innovation in advancing healthcare technologies. His work not only enhances our understanding of tumor dynamics but also paves the way for improved diagnostic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…